Treating neovascular age-related macular degeneration in the era of COVID-19.

Antaki, Fares; Dirani, Ali

Antaki, Fares; Dirani, Ali.

Antaki F; Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Dirani A; Department of Ophthalmology, Centre Universitaire d'Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Québec, Canada. drdirani@gmail.com.

Graefes Arch Clin Exp Ophthalmol ; 258(7): 1567-1569, 2020 07.

Article in English | MEDLINE | ID: covidwho-98832

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Betacoronavirus; Coronavirus Infections/epidemiology; Disease Management; Disease Transmission, Infectious/prevention & control; Pandemics; Pneumonia, Viral/epidemiology; Wet Macular Degeneration/drug therapy; Aged; COVID-19; Comorbidity; Disease Transmission, Infectious/statistics & numerical data; Humans; Intravitreal Injections; SARS-CoV-2; Wet Macular Degeneration/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Disease Transmission, Infectious / Disease Management / Angiogenesis Inhibitors / Wet Macular Degeneration / Pandemics / Betacoronavirus Type of study: Observational study Limits: Aged / Humans Language: English Journal: Graefes Arch Clin Exp Ophthalmol Year: 2020 Document Type: Article Affiliation country: S00417-020-04693-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google